Active Ingredient: TRETINOIN
Proprietary Name: RENOVA
Dosage Form; Route of Administration: CREAM; TOPICAL
Strength: 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N019963
Product Number: 001
Approval Date: Dec 29, 1995
Applicant Holder Full Name: VALEANT PHARMACEUTICALS NORTH AMERICA LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information
